Skip to Content
Merck
CN
  • Full-mouth rehabilitation for a patient with dentinogenesis imperfecta: a clinical report.

Full-mouth rehabilitation for a patient with dentinogenesis imperfecta: a clinical report.

The Journal of oral implantology (2013-01-08)
Sompop Bencharit, Michael B Border, C Russell Mack, Warren C Byrd, John T Wright
ABSTRACT

Dentinogenesis imperfecta (DI) is a genetic disorder affecting the structural integrity of the dentin that can result in weakened dentin. The affected teeth, especially posterior teeth, often need to be extracted due to severe wear or fracture. This frequently yields a loss of posterior occlusion and occlusal vertical dimension. Besides wear and fracture, anterior teeth often have an unesthetic appearance because of discoloration. Current treatments of choice, including composite bonding restorations and, more recently, all-ceramic restorations, are typically suggested to preserve the remaining teeth and tooth structure. However, there are a limited number of studies on dental implants in patients with DI. The effectiveness of dentin bonding and dental implants in patients with DI is not known. This clinical report describes a 32-year-old Asian woman with DI who underwent full-mouth rehabilitation. The posterior occlusion, mostly in the molar areas, was restored with dental implants and ceramometal restorations. The anterior teeth and premolars were restored with bonded lithium disilicate glass-ceramic pressed veneers and crowns made with computer-aided design/computer-aided manufacturing. This case demonstrates that restoring functional occlusion and esthetics for a patient with DI can be completed successfully using contemporary implant therapy and adhesive dentistry.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Magnesium oxide, tested according to Ph. Eur., heavy
Sigma-Aldrich
Magnesium oxide, ≥99% trace metals basis, -325 mesh
Sigma-Aldrich
Magnesium oxide, ≥99.99% trace metals basis
Sigma-Aldrich
Magnesium oxide, 99.99% trace metals basis
Sigma-Aldrich
Magnesium oxide, light, 95%
Sigma-Aldrich
Magnesium oxide, nanopowder, ≤50 nm particle size (BET)
Sigma-Aldrich
Magnesium oxide, ACS reagent, 97%
Sigma-Aldrich
Magnesium oxide, (single crystal substrate), ≥99.9% trace metals basis, <100>, L × W × thickness 10 mm × 10 mm × 0.5 mm
Sigma-Aldrich
Magnesium oxide, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E 530, light, 98.0-100.5% (calc. for dried substance)
Sigma-Aldrich
Magnesium oxide, -10-+50 mesh, 98%
Sigma-Aldrich
Magnesium oxide, BioUltra, ≥97.0% (calcined substance, KT)
Sigma-Aldrich
Zinc oxide, nanopowder, <50 nm particle size (BET), >97%
Sigma-Aldrich
Zinc oxide, dispersion, nanoparticles, <100 nm particle size (TEM), ≤40 nm avg. part. size (APS), 20 wt. % in H2O
Sigma-Aldrich
Zinc oxide, nanopowder, ≤50 nm particle size
Sigma-Aldrich
Zinc oxide, ReagentPlus®, powder, <5 μm particle size, 99.9%
Sigma-Aldrich
Zinc oxide, 99.99% trace metals basis
Sigma-Aldrich
Zinc oxide, puriss. p.a., ACS reagent, ≥99.0% (KT)
Sigma-Aldrich
Zinc oxide, 99.999% trace metals basis
Sigma-Aldrich
Zinc oxide, puriss., meets analytical specification of Ph. Eur., BP, USP, 99-100.5% (calc. for dried substance)
Supelco
Zinc oxide, analytical standard
Sigma-Aldrich
Zinc oxide, nanowires, Length 1 um